-
Treatment intensity and risk of chronic health conditions and late mortality among long-term survivors of Wilms tumor: a report from the Childhood Cancer Survivor Study.
Author(s): Weil
Venue: American Society of Clinical Oncology Annual Meeting
-
Neuromuscular dysfunction and associated health/socioeconomic outcomes: a report from the Childhood Cancer Survivor Study.
Author(s): Rodwin
Venue: American Society of Clinical Oncology Annual Meeting
-
HAGHL genetic variants increase first fracture risk (FFR) in female childhood cancer survivors: a report from the Childhood Cancer Survivor Study (CCSS) and St. Jude Lifetime cohort study (SJLIFE).
Author(s): Im
Venue: American Society of Clinical Oncology Annual Meeting
-
Underdiagnosis and undertreatment of modifiable cardiovascular risk factors: a Childhood Cancer Survivor Study (CCSS) report.
Author(s): Chow
Venue: American Society of Clinical Oncology Annual Meeting
-
Clinical and genetic factors for radiation-associated ototoxicity: a report from the Childhood Cancer Survivor Study and the St. Jude Lifetime cohort.
Author(s): Trendowski
Venue: American Society of Clinical Oncology Annual Meeting
-
Assisted reproductive technology outcomes in childhood cancer survivors: a report from the Childhood Cancer Survivors Study.
Author(s): Keefe
Venue: American Society of Clinical Oncology Annual Meeting
-
Lung cancer as a subsequent neoplasm: a report from the Childhood Cancer Survivor Study (CCSS).
Author(s): Ghosh
Venue: American Society of Clinical Oncology Annual Meeting
-
Health and cancer concerns among siblings of childhood cancer survivors: a report from the Childhood Cancer Survivor Study (CCSS).
Author(s): Morales
Venue: American Society of Clinical Oncology Annual Meeting
-
Feasibility and acceptability of a wearable respiration-sensing device for supporting pain management in adult survivors of childhood cancer with chronic pain.
Author(s): Alberts
Venue: Canadian Pain Society Annual Meeting
-
The St. Jude survivorship portal links whole-genome genetic data with clinical therapy and outcome phenotypes for 7302 pediatric cancer survivors.
Author(s): Zhou
Venue: American Association for Cancer Research Annual Meeting